Request a Quote |

Cyprotex starts working with the NIH Chemical Genomics Centre

Cyprotex is pleased to announce that it has been chosen to work with the National Institutes of Health Chemical Genomics Centre (NCGC), based in Rockville, Maryland USA.

The NCGC has been established by the National Institute of Health, with a view to creating a national resource in chemical probe development. The centre uses the latest industrial-scale technologies in order to collect data for defining the cross-section between chemical space and biological activity.

Cyprotex's automated facilities satisfy the NCGC's requirements by providing exceptionally robust data and rapid turnaround while profiling the in vitro properties of a wide range of compounds.

The data generated by Cyprotex will then be published on the PubChem website(, a National Centre for Biotechnology Information (NCBI) program providing public information on the biological activities of small molecules.

Commenting on the agreement, Robert Morrison Atwater, CEO of Cyprotex plc said: "We are looking forward to initiating this new relationship with NIH and are delighted that Cyprotex has been chosen as their partner for this valuable and exciting project."

Cyprotex is a specialist provider of ADME (Absorption, Distribution, Metabolism and Excretion) screening and predictive services. Its unique Cloe� technology, based on a highly automated laboratory and IT software platform, ensures optimal performance and quality of our services for our clients. This is now being recognised within the industry leading to a rapid expansion of our customer base.

For further information:
Cyprotex PLC

Helen Gill PhD, Product Development Manager
Tel: +44 (0)1625 505 100

Contact us

News categories


Contact us to discuss your ADME Tox issues or request a quote

North America (East Coast): +1-888-297-7683
Europe: +44 (0)1625 5051000


or fill out the form below:

Please give details of the assays you are interested in. Where appropriate please specify one or more species (human, rat, mouse etc.), isoforms (CYP1A1,CYP1B1, etc) or other relevant details.

By clicking on ‘Send’ I agree that my data is being transferred and used by Cyprotex and the affiliated Evotec Group. The Evotec Group currently consists of the following companies. For further details please see our privacy policy.

If you would like to be kept informed of our latest services, new research, events and other news please tick the box below: